Photodynamic therapy: A clinical reality in the treatment of cancer

Lancet Oncology

Volumn 1, Issue 4, 2000, Pages 212-219

  Hopper, Colin ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

CLINICAL TRIAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; LUNG TUMOR; MALE; METHODOLOGY; NEOPLASM; PHOTOCHEMOTHERAPY; PROGNOSIS; REVIEW; SKIN TUMOR; TREATMENT OUTCOME;

CLINICAL TRIALS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROGNOSIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0034585873     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00166-2     Document Type: Review

References (36)

1. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 49:1999;1-7.
2. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 348:1996;584-585.
3. Grant WE, Hopper C, Speight PM, et al. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol. 107:1993;1140-1145.
4. Fan KF, Hopper C, Speight PM, et al. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 78:1996;1374-1383.
5. Fan KF, Hopper C, Speight PM, et al. Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer. 73:1997;25-32.
6. Nseyo UO, Shumaker B, Klein EA, et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma of the bladder. J Urol. 160:1998;39-44.
7. Uchibayashi T, Koshida K, Kunimi K, et al. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder. Br J Cancer. 71:1995;625-628.
8. Kriegmair M, Baumgartner R, Lumper W, et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol. 77:1996;667-671.
9. Wilson BD, Mang TS, Stoll H, et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol. 128:1992;1597-1601.
10. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 6:1990;143-148.
11. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 133:1995;282-288.
12. Cairnduff F, Stringer MR, Hudson EJ, et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 69:1994;605-608.
13. Kübler AC, Haase T, Staff C, et al. Photodynamic therapy of primary non-melanomatous skin tumours of the head and neck. Lasers Surg Med. 25:1999;60-68.
14. Sperduto PW, DeLaney TF, Thomas G, et al. Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys. 21:1991;441-446.
15. Biel MA. Photodynamic therapy using Photofrin and Foscan and the treatment of malignancies of the head and neck. Proc SPIE-Int Soc Opt Eng. 3247:1998;25-30.
16. Gluckman JL. Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope. 101:1991;36-42.
17. Hopper C. Photodynamic therapy with Foscan (temoporfin) in primary squamous cell carcinoma of the head and neck. Proceedings Fifth International Congress on Head and Neck Oncology; San Francisco, USA. July 2000.
18. Tan IB. Foscan-mediated photodynamic therapy (Foscan-PDT) in recurrent and second primary oral cavity cancers. Laryngo-Rhino-Otology. 79:(suppl 1):2000;S318.
19. Kübler A. Photodynamic therapy for the treatment of lip cancer. Proceedings of the 15th European Association for Cranio-Maxillofacial Surgery; 2000 Sept 5-9; Edinburgh, UK. Harcourt Brace; 2000.
20. Wenig BL, D'Cruz A, Iqbal A, Bryce RP. Foscan-mediated photodynamic therapy (Foscan PDT) in the palliative treatment of advanced head and neck cancer. Proc Am Soc Clin Oncol (abstr). 19:2000;165.
21. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer: the Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol. 11:1993;1852-1857.
22. Moghissi K, Dixon K, Stringer MR, et al. The place of bronchoscopic photodynamic therapy (PDT) in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothoracic Surg. 15:1999;1-6.
23. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 72:1997;595-602.
24. Savary JF, Grosjean P, Monnier P, et al. Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases. Endoscopy. 30:1998;258-265.
25. Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc. 42:1995;507-512.
26. Moghissi K, Dixon K, Thorpe JAC, et al. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur J Cardiothorac Surg. 17:2000;95-100.
27. McCaughan JS Jr, Ellison EC, Guy JT, et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg. 62:1996;1005-1009.
28. Ell C, Gossner L, May A, et al. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut. 43:(3):1998;345-349.
29. Grosjean P, Savary JF, Mizeret J, et al. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin. J Clin Laser Med Surg. 14:1996;281-287.
30. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleuralphotodynamic therapy: results of a phase I trial. Ann Surg Oncol. 1:1994;28-37.
31. Baas P, Murrer L, Zoetmulder FAN, et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer. 76:1997;819-826.
32. Takita H, Dougherty TJ. Intracavity photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol. 11:1995;368-371.
33. Ris HB, Altermatt HJ, Nachbur B, et al. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med. 18:1996;39-45.
34. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B. 36:1996;157-168.
35. Lowdell CP, Ash DV, Driver I, et al. Interstitial photodynamic therapy: clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours. Br J Cancer. 67:1993;1398-1403.
36. Hopper C, Suhr M, Jones L, et al. Interstitial photodynamic therapy in head and neck cancer. Br J Cancer 2000; 83 (suppl 1): abstr 79.